Former U.S. President Donald Trump has selected Dr. Heidi Overton, a senior domestic policy advisor serving in his White House, as his nominee to head the U.S. Food and Drug Administration (FDA). If the U.S. Senate votes to confirm her appointment, Overton will step into the role vacated by former FDA commissioner Marty Makary, who resigned from the post in May following public disagreements with the White House over the public safety risks of flavored vaping products.
In a public post shared to his Truth Social platform on Wednesday, Trump lavished praise on his nominee, calling Overton a “rockstar” within his administration. He emphasized that she has built a reputation for tackling the nation’s most intractable policy challenges and delivering practical solutions aligned with the administration’s priorities for the country.
Overton, who regularly briefs the president on domestic health policy matters, made headlines earlier this month during an Oval Office announcement focused on rolling back the number of mandatory childhood vaccinations. During that event, she delivered sharp criticism of so-called “blue states” led by Democratic governors and legislatures, urging these jurisdictions to adopt the White House’s new framework, which she described as the “gold standard” for vaccination policy.
Should she secure confirmation, Overton will inherit a broad set of core responsibilities at the FDA, ranging from verifying the safety and effectiveness of all prescription medications sold in the U.S. to overseeing federal regulation of tobacco and nicotine products. Like most senior health officials in the second Trump administration, Overton is a staunch ally of the White House’s “Make America Healthy Again” policy movement.
Before joining the administration, Overton served as chief policy officer at the America First Policy Institute, a conservative Washington D.C.-based think tank closely aligned with Trump’s policy agenda. A well-known opponent of abortion rights, she has previously labeled abortion “corrosive” to women’s health and has repeatedly called on the FDA to tighten restrictions and crack down on medication abortion access.
Continuing his endorsement on Truth Social, Trump argued that Overton’s leadership is urgently needed at the agency to maintain the United States’ global position as a leader in scientific discovery and medical innovation. He added that Overton is “smart and respected by all” and that her tenure at the FDA would continue the administration’s commitment to putting “America First” and building a healthier nation.
Industry and political sources familiar with the selection process have confirmed that Overton is Trump’s third pick for the FDA commissioner role, after the president’s first two choices — acting FDA head Kyle Diamantas and former Republican Congressman Brad Wenstrup — withdrew from consideration. Her nomination comes at a fraught moment for federal public health policy: the administration is already facing widespread criticism over its slow response to a national cyclospora parasite outbreak, and conservative activists are ramping up pressure on the FDA to restrict access to abortion medications.
A native of the southwest, Overton earned her medical degree from the University of New Mexico School of Medicine and went on to complete postgraduate public health training at the Johns Hopkins University Bloomberg School of Public Health.